Hydroxychloroquine attenuates double‐stranded RNA‐stimulated hyper‐phosphorylation of tristetraprolin/ZFP36 and AU‐rich mRNA stabilization
Immunology · 2024
DOI: 10.1111/imm.13835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Edward G Hitti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biomedicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Tristetraprolin, RNA Stability, Hydroxychloroquine, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal Specialist Hospital and Research Centre.
Abstract (Originalsprache)
The human innate immune system recognizes dsRNA as a pathogen‐associated molecular pattern that induces a potent inflammatory response. The primary source of pathogenic dsRNA is cells infected with replicating viruses, but can also be released from uninfected necrotic cells. Here, we show that the dsRNA poly(I:C) challenge in human macrophages activates the p38 MAPK‐MK2 signalling pathway and subsequently the phosphorylation of tristetraprolin (TTP/ZFP36). The latter is an mRNA decay‐promoting protein that controls the stability of AU‐rich mRNAs (AREs) that code for many inflammatory mediators. Hydroxychloroquine (HCQ), a common anti‐malaria drug, is used to treat inflammatory and autoimmune disorders and, controversially, during acute COVID‐19 disease. We found that HCQ reduced the dsRNA‐dependent phosphorylation of p38 MAPK and its downstream kinase MK2. Subsequently, HCQ reduced the abundance and protein stability of the inactive (phosphorylated) form of TTP. HCQ reduced the levels and the mRNA stability of poly (I:C)‐induced cytokines and inflammatory mRNAs like TNF, IL‐6, COX‐2, and IL‐8 in THP‐1 and primary blood monocytes. Our results demonstrate a new mechanism of the anti‐inflammatory role of HCQ at post‐transcriptional level (TTP phosphorylation) in a model of dsRNA activation, which usually occurs in viral infections or RNA release from necrotic tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biomedicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
ORCID-Profile: Khalid S A Khabar
Förderung
- King Faisal Specialist Hospital and Research Centre
Zitieren
APA
Hitti, E. G., Muazzen, Z., Moghrabi, W., Al-Yahya, S., & Khabar, K. S. A. (2024). Hydroxychloroquine attenuates double‐stranded RNA‐stimulated hyper‐phosphorylation of tristetraprolin/ZFP36 and AU‐rich mRNA stabilization. Immunology. https://doi.org/10.1111/imm.13835
Vancouver
Hitti EG, Muazzen Z, Moghrabi W, Al-Yahya S, Khabar KSA. Hydroxychloroquine attenuates double‐stranded RNA‐stimulated hyper‐phosphorylation of tristetraprolin/ZFP36 and AU‐rich mRNA stabilization. Immunology. 2024. doi:10.1111/imm.13835
BibTeX
@article{Hitti2024,
author = {Hitti, Edward G and Muazzen, Zeyad and Moghrabi, Walid and Al-Yahya, Suhad and Khabar, Khalid S A},
title = {Hydroxychloroquine attenuates double‐stranded RNA‐stimulated hyper‐phosphorylation of tristetraprolin/ZFP36 and AU‐rich mRNA stabilization},
journal = {Immunology},
year = {2024},
doi = {10.1111/imm.13835}
}
EUVIMED